This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Jul;12(7):374.

doi: 10.1038/nrclinonc.2015.94. Epub 2015 May 19.

Colorectal cancer: POLR2A deletion with TP53 opens a window of opportunity for therapy

PMID: 25985938
DOI: 10.1038/nrclinonc.2015.94

Comment

Colorectal cancer: POLR2A deletion with TP53 opens a window of opportunity for therapy

Alessia Errico. Nat Rev Clin Oncol. 2015 Jul.

. 2015 Jul;12(7):374.

doi: 10.1038/nrclinonc.2015.94. Epub 2015 May 19.

Author

PMID: 25985938
DOI: 10.1038/nrclinonc.2015.94

No abstract available

PubMed Disclaimer

Comment on

TP53 loss creates therapeutic vulnerability in colorectal cancer.
Liu Y, Zhang X, Han C, Wan G, Huang X, Ivan C, Jiang D, Rodriguez-Aguayo C, Lopez-Berestein G, Rao PH, Maru DM, Pahl A, He X, Sood AK, Ellis LM, Anderl J, Lu X. Liu Y, et al. Nature. 2015 Apr 30;520(7549):697-701. doi: 10.1038/nature14418. Epub 2015 Apr 22. Nature. 2015. PMID: 25901683 Free PMC article.

Similar articles

TP53 loss creates therapeutic vulnerability in colorectal cancer.
Liu Y, Zhang X, Han C, Wan G, Huang X, Ivan C, Jiang D, Rodriguez-Aguayo C, Lopez-Berestein G, Rao PH, Maru DM, Pahl A, He X, Sood AK, Ellis LM, Anderl J, Lu X. Liu Y, et al. Nature. 2015 Apr 30;520(7549):697-701. doi: 10.1038/nature14418. Epub 2015 Apr 22. Nature. 2015. PMID: 25901683 Free PMC article.
Colorectal cancer: A circuitous way to target p53.
Seton-Rogers S. Seton-Rogers S. Nat Rev Cancer. 2015 Jun;15(6):318-9. doi: 10.1038/nrc3962. Epub 2015 May 14. Nat Rev Cancer. 2015. PMID: 25971675 No abstract available.
Cancer: An essential passenger with p53.
Bradner JE. Bradner JE. Nature. 2015 Apr 30;520(7549):626-7. doi: 10.1038/nature14390. Epub 2015 Apr 22. Nature. 2015. PMID: 25901678 No abstract available.
[TP53 mutations and molecular epidemiology].
Otsuka K, Ishioka C. Otsuka K, et al. Gan To Kagaku Ryoho. 2007 May;34(5):683-9. Gan To Kagaku Ryoho. 2007. PMID: 17496437 Review. Japanese.
P53 abnormalities and outcomes in colorectal cancer: a systematic review.
Smith FM, Stephens RB, Kennedy MJ, Reynolds JV. Smith FM, et al. Br J Cancer. 2005 May 9;92(9):1813. doi: 10.1038/sj.bjc.6602589. Br J Cancer. 2005. PMID: 15856032 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Polymorphisms in CARS are associated with gastric cancer risk: a two-stage case-control study in the Chinese population.
Tian T, Xiao L, Du J, Zhu X, Gu Y, Qin N, Yan C, Liu L, Ma H, Jiang Y, Chen J, Yu H, Dai J. Tian T, et al. Gastric Cancer. 2017 Nov;20(6):940-947. doi: 10.1007/s10120-017-0717-6. Epub 2017 Apr 13. Gastric Cancer. 2017. PMID: 28409418
FXR1 regulates transcription and is required for growth of human cancer cells with TP53/FXR2 homozygous deletion.
Fan Y, Yue J, Xiao M, Han-Zhang H, Wang YV, Ma C, Deng Z, Li Y, Yu Y, Wang X, Niu S, Hua Y, Weng Z, Atadja P, Li E, Xiang B. Fan Y, et al. Elife. 2017 Aug 2;6:e26129. doi: 10.7554/eLife.26129. Elife. 2017. PMID: 28767039 Free PMC article.
BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A.
Mao CG, Jiang SS, Shen C, Long T, Jin H, Tan QY, Deng B. Mao CG, et al. Thorac Cancer. 2020 Nov;11(11):3326-3336. doi: 10.1111/1759-7714.13676. Epub 2020 Oct 1. Thorac Cancer. 2020. PMID: 33001583 Free PMC article.
POLR2A Promotes the Proliferation of Gastric Cancer Cells by Advancing the Overall Cell Cycle Progression.
Jiang Q, Zhang J, Li F, Ma X, Wu F, Miao J, Li Q, Wang X, Sun R, Yang Y, Zhao L, Huang C. Jiang Q, et al. Front Genet. 2021 Nov 25;12:688575. doi: 10.3389/fgene.2021.688575. eCollection 2021. Front Genet. 2021. PMID: 34899822 Free PMC article.
A bioinformatic analysis identifies circadian expression of splicing factors and time-dependent alternative splicing events in the HD-MY-Z cell line.
Genov N, Basti A, Abreu M, Astaburuaga R, Relógio A. Genov N, et al. Sci Rep. 2019 Jul 30;9(1):11062. doi: 10.1038/s41598-019-47343-w. Sci Rep. 2019. PMID: 31363108 Free PMC article.

References

1. Nature. 2015 Apr 30;520(7549):697-701 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal